Additional file 4: of The amount of late gadolinium enhancement outperforms current guideline-recommended criteria in the identification of patients with hypertrophic cardiomyopathy at risk of sudden cardiac death

Table S3. Event distribution according to the studied classifications with follow-up time censored at 5-years. (DOC 49 kb)